aibioAspire Biopharma (now Aspire-Lakewood Holdings) delays 2024 annual report
Tickers ASBP
The company said it could not file by April 15, 2025, the original due date, because it needs more time for its financial statements.
Key facts
- Company
- Aspire-Lakewood Holdings, Inc. (NASDAQ: ASBP)
- News type
- Distress
- Primary source
- Aspire-Lakewood Holdings, Inc. NT 10-K (2025-03-31)
Aspire Biopharma Holdings, Inc. (now Aspire-Lakewood Holdings, Inc.) has told the Securities and Exchange Commission that it cannot file its annual report for the fiscal year ended December 31, 2024 by April 15, 2025, the original due date. The notification of late filing is dated March 31, 2025.
The company said it needs more time to complete its financial statements and could not finish them without unreasonable effort or expense.
Aspire said it expects to file no later than the fifth calendar day after the prescribed filing date. It said it has filed all other periodic reports required over the preceding 12 months, and it does not expect a significant change in results of operations from the prior fiscal year.
The notice names Kraig T. Higginson, Chief Executive Officer, as the contact. The company lists its principal office in Humacao, Puerto Rico.